Amylyx Pharmaceuticals inc. (AMLX) PT Lowered to $8 at H.C. Wainwright
Tweet
Share
E-mailGet Alerts AMLX Hot Sheet
Price: $22.48 -3.73%
Rating Summary:
10 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Rating Summary:
10 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Join SI Premium – FREE
H.C. Wainwright analyst Andrew Fein lowered the price target on Amylyx Pharmaceuticals inc. (NASDAQ: AMLX) to $8.00 (from $42.00) while maintaining a Buy rating.
You May Also Be Interested In
- Golar LNG Ltd. (GLNG) PT Raised to $70 at BTIG
- Yeti Holdings Inc. (YETI) PT Raised to $56 at Raymond James
- Birkenstock Holding plc (BIRK) PT Raised to $44 at Morgan Stanley
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
